CITIUS ONCOLOGY, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Webb Carol | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Czuczman Myron | Chief Medical Officer | Award / Grant | 825,000 | — | — | 825,000 | Sep 19, 2025 |
| HOLUBIAK MYRON Z | Secretary | Award / Grant | 850,000 | — | — | 850,000 | Sep 19, 2025 |
| Mazur Leonard L | Chief Executive Officer | Award / Grant | 1,700,000 | — | — | 1,700,000 | Sep 19, 2025 |
| Bartushak Jaime | Chief Financial Officer | Award / Grant | 825,000 | — | — | 825,000 | Sep 19, 2025 |
| Smith Robert Joseph | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Mayersohn Joel David | — | Award / Grant | 300,000 | — | — | 321,228 | Sep 19, 2025 |
| MCGRATH DENNIS M | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Dutia Suren G | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Holuka Eugene Myron | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Webb Carol | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Holuka Eugene Myron | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Mayersohn Joel David | — | Award / Grant | 300,000 | — | — | 321,228 | Sep 19, 2025 |
| HOLUBIAK MYRON Z | Secretary | Award / Grant | 850,000 | — | — | 850,000 | Sep 19, 2025 |
| MCGRATH DENNIS M | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Bartushak Jaime | Chief Financial Officer | Award / Grant | 825,000 | — | — | 825,000 | Sep 19, 2025 |
| Smith Robert Joseph | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Mazur Leonard L | Chief Executive Officer | Award / Grant | 1,700,000 | — | — | 1,700,000 | Sep 19, 2025 |
| Dutia Suren G | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Czuczman Myron | Chief Medical Officer | Award / Grant | 825,000 | — | — | 825,000 | Sep 19, 2025 |
| HOLUBIAK MYRON Z | Secretary | Award / Grant | 100,000 | — | — | 100,000 | Sep 19, 2025 |
| Smith Robert Joseph | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Dutia Suren G | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| MCGRATH DENNIS M | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Mazur Leonard L | Chief Executive Officer | Award / Grant | 1,700,000 | — | — | 1,700,000 | Sep 19, 2025 |
| Webb Carol | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Czuczman Myron | Chief Medical Officer | Award / Grant | 825,000 | — | — | 825,000 | Sep 19, 2025 |
| Holuka Eugene Myron | — | Award / Grant | 300,000 | — | — | 300,000 | Sep 19, 2025 |
| Bartushak Jaime | Chief Financial Officer | Award / Grant | 825,000 | — | — | 825,000 | Sep 19, 2025 |
| Mayersohn Joel David | — | Award / Grant | 300,000 | — | — | 321,228 | Sep 19, 2025 |
| Mayersohn Joel David | — | Other | 21,228 | — | — | 21,228 | Jul 28, 2025 |